Skip to main content

UNC School of Medicine Physician Scientists Training Program Gives Awards to Cultivate the Careers of Upcoming Physician-Scientists

June 28, 2022

Medicine, like any other scientific field, cannot progress forward without the hard work of new, cutting-edge researchers. In the Department of Medicine, three physician scientist trainees are working to improve the lives of patients who have inflammatory bowel disease, cancer, and food allergies. In light of their promising, hard work, all three have received support … Continued

Dr. Shakira J. Grant selected for PRIDE, hopes to encourage others to find their purpose

May 2, 2022

As an assistant professor in the Divisions of Hematology and Geriatric Medicine, and a board-certified Geriatric-Hematologist, Dr. Shakira J. Grant, MBBS, is no stranger to success, but she has had to overcome many challenges along the way. Now, selected for the 2022 Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) cohort, she … Continued

DVT Awareness Month: Spotlighting Hematology Trial That Serves COVID Patients, BRC’s Thrombosis Related Research

March 14, 2022

March is Deep-Vein Thrombosis (DVT) Awareness Month, a public health initiative that seeks to aid understanding of a commonly occurring and potentially life-threatening medical condition among the general population. DVT is commonly referred to as a blood clot (thrombus) that forms in one or more veins located deep inside the body. Did you know, almost one … Continued

Key awarded a 5-year, $2.2 million T32 grant from NHLBI

February 23, 2022

Nigel Key, MB, ChB, FRCP has been awarded a 5-year, $2.2 million T32 grant from the National Heart, Lung, and Blood Institute (NHLBI). Now closely aligned with the benign hematology research areas of focus in the Blood Research Center (hemostasis, thrombosis and sickle cell disease), the program will continue to recruit MD and PhD trainees … Continued

Clinical Challenges: Using MRD in Chronic Lymphocytic Leukemia Management

December 29, 2021

For patients with chronic lymphocytic leukemia (CLL), minimal residual disease (MRD) has emerged as a highly sensitive indicator of disease burden during and at the end of treatment, and has correlated with time-to-event outcomes. Use of MRD has shown promise for guiding duration of treatment for CLL patients on time-limited therapy. “MRD measurement is not … Continued

New Approaches to Hemophilia Treatment: ‘Our Cup Runneth Over’

December 28, 2021

In a session titled “Hemophilia Update: Our Cup Runneth Over,” presented at the 2021 annual meeting of the American Society of Hematology (ASH), experts in the treatment of bleeding disorders discussed the optimal use of factor concentrates in people with hemophilia, new and investigational alternatives to factor concentrates, and the promise of long-time control or … Continued

Hematology/Oncology Diversity and Inclusion Initiatives

October 27, 2021

UNC Lineberger Comprehensive Cancer Center Equity Council Four members of the Department of Medicine are working to bring diversity, equity and inclusion principles into critical areas of UNC Lineberger. “This is a group of 14 faculty, graduate students, and staff–and we’re in the process of identifying patients and community members–coming together to develop a system that … Continued

Serody Receives Grant to Evaluate Epigenetic Changes in Innate Immune Cells During Stem Cell Transplantation

September 30, 2021

Jonathan Serody, MD, the Elizabeth Thomas Professor of Medicine, Microbiology and Immunology, and chief of the Division of Hematology, received an NIH (NHLBI) R01 grant of $3.4M to evaluate epigenetic changes in innate lymphoid cells as a mediator of acute Graft-Versus-Host Disease (GvHD) after stem cell transplantation. The grant is in collaboration with Samantha Pattenden, … Continued